Researchers Discover a Key to the Survival of Dormant Breast Cancer Cells
A common anti-diabetes drug being tested in many clinical trials as an anti-cancer agent activated fat metabolism that promoted the survival of dormant breast cancer cells, suggesting that the drug has context-dependent effects on cancer cells.
Source: News at Dartmouth Medical School - Category: Hospital Management Authors: NonPerson Geisel Web Service Acct Tags: News Press Release breast cancer cancer research Home-feature Norris Cotton Cancer Center Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Clinical Trials | Diabetes | Endocrinology | Hospital Management